SCHEMBL6810144

SCHEMBL6810144

O=C(O)C(Cc1ccc([N+](=O)[O-])cc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
EPHX1 P07099 1/20 0.50
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
CES2 O00748 1/20 0.47
CES1 P23141 1/20 0.47
ANPEP P15144 1/20 0.47
ERAP2 Q6P179 1/20 0.47
ERAP1 Q9NZ08 1/20 0.47
CNR1 P21554 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6810226 1.00 KMT2A (0.52) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL7429456 0.94 NPC1 (0.53) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL27581401 0.88 ESR1 (0.54) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL2658881 0.83 ALDH1A1 (0.48) KMT2AMEN1NPC1TP53RAB9A
Toluene SCHEMBL28163126 0.83 RAB9A (0.45) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL6625969 0.82 EPHX1 (0.69) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL27581400 0.82 NPC1 (0.54) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL11262646 0.82 CYP1A2 (0.54) KMT2AMEN1NPC1TP53RAB9A
SCHEMBL599399 0.81 EPHX1 (0.71) EPHX1CYP1A2CYP2C19CPA1
SCHEMBL67234 0.81 EPHX1 (0.71) EPHX1CYP1A2CYP2C19CPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9718763-B2 Catalytic ester decarbonylation REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2017-08-01 US disclosed
US-20160194276-A1 CATALYTIC ESTER DECARBONYLATION REGENTS OF THE UNIVERSITY OF MINNESOTA 2016-07-07 US disclosed
US-20040014161-A1 pH-indicator based assay for selective enzymes THERMOGEN, INC. 2004-01-22 US disclosed
US-20020177180-A1 pH-indicator based assay for selective enzymes THERMOGEN, INC. 2002-11-28 US disclosed
EP-1090139-A1 PH-INDICATOR BASED ASSAY FOR SELECTIVE ENZYMES Thermogen, Inc. (US) 2001-04-11 EP disclosed
WO-1999067420-A1 pH-INDICATOR BASED ASSAY FOR SELECTIVE ENZYMES THERMOGEN, INC. (US) 1999-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194276-A1 CATALYTIC ESTER DECARBONYLATION DECR1, C1S, CBR3 KMT2A 1979/4885MEN1 1360/4885NPC1 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.